Advertisement

Topics

Genentech Bets On Kineta's Early-Stage, Disease-Modifying Pain Therapy

04:00 EDT 16 Apr 2018 | SCRIP

Genentech partners with the Seattle biotech on a non-opioid approach to chronic pain. Kineta says there's disease-modifying potential.

      

Related Stories

 

Original Article: Genentech Bets On Kineta's Early-Stage, Disease-Modifying Pain Therapy

NEXT ARTICLE

More From BioPortfolio on "Genentech Bets On Kineta's Early-Stage, Disease-Modifying Pain Therapy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Pain Disorder
Pain is a feeling (sharp or dull) triggered in the nervous system which can be transient or constant. Pain can be specific to one area of the body eg back, abdomen or chest or more general all over the body eg muscles ache from the flu. Without pain ...